2-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 1g

2-Chloro-3-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 100mg

3-Chloro-2-fluoro-6-(trifluoromethyl)benzoic acid, 95.0%, 25g

6-(4-methoxyphenyl)-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid, 95.0%, 5g

8-Chloro-1-naphthoic acid, 97%, 100mg

1-Butyl-decahydronaphthalene, 95.0%, 5g

Azetidin-3-yl acetate 2,2,2-trifluoroacetate, 98.0%, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(1H-pyrrolo[2,3-b]pyridin-3-yl)propanoic acid, 95%, 1g

1-ethyl-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 1g

N1-((1S,2R,4S)-4-(Dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)-N2-(pyridin-2-yl)oxalamide (Edoxaban Impurity), 98%, 50mg

trans,trans-1,4-Diphenyl-1,3-butadiene>99.0%(GC)5g

tert-Butyl (3-amino-2,6-difluorophenyl)carbamate, 95.0%, 1g

S-Ethyl Trifluorothioacetate [Trifluoroacetylating Agent for Peptides Research]>98.0%(GC)5mL